AlphaRx regains all rights to Indaflex from Cypress Bioscience AlphaRx, Inc. today announced that it offers entered into an contract with Cypress Bioscience , under which AlphaRx is definitely regaining all rights to Indaflex from Cypress Bioscience, which AlphaRx acquired licensed to Proprius Pharmaceuticals previously, which was subsequently obtained by Cypress Bioscience decanoate300.com decanoate300.com . With this Cypress colleagues, we’ve advanced Indaflex to this late-stage of development successfully, said Michael Lee, CEO of AlphaRx Inc.
Also in global health news: Aid in S. Somalia; virus-resistant mosquitoes; composting toilets in Haiti; U.S. Congressional Group appointments India WFP Halts Aid Distribution In Southern Somalia The U.N. World Food System announced Tuesday that it’s been forced to halt ‘aid distribution to about 1 million people in southern Somalia due to attacks against personnel and demands by armed groups that aid groups remove females from their teams,’ the Associated Press reports. Relating to WFP spokesperson Emilia Casella, the company is relocating personnel and supplies from regions in the south, which are managed by the al-Shabab Islamist group, to northern and central Somalia . ‘The al-Shabab militant group provides repeatedly threatened the WFP – who it accuses of ruining regional farming by forcing Somalis to depend on imports,’ the BBC reports .